Connection

Viroj Wiwanitkit to Lupus Erythematosus, Systemic

Back to Details
This is a "connection" page, showing publications Viroj Wiwanitkit has written about Lupus Erythematosus, Systemic.
Viroj Wiwanitkit
Connection Strength
1.809
Lupus Erythematosus, Systemic
  1. Hydroxychloroquine, TTP, COVID-19, and SLE Turk J Haematol. 2021 02 25; 38(1):99-100.
    View in: PubMed
    Score: 0.389
  2. Systemic lupus erythematosus, varicella-like rash, and COVID-19. J Med Virol. 2021 03; 93(3):1212.
    View in: PubMed
    Score: 0.382
  3. Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão et al and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal. Ann Rheum Dis. 2021 02; 80(2):e24.
    View in: PubMed
    Score: 0.372
  4. Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus. Reumatismo. 2019 10 24; 71(3):171.
    View in: PubMed
    Score: 0.358
  5. Prolactin and systemic lupus erythematosus. Immunol Res. 2017 08; 65(4):975.
    View in: PubMed
    Score: 0.307
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.